GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Vytrus Biotech SA (XMAD:VYT) » Definitions » Pretax Margin %

Vytrus Biotech (XMAD:VYT) Pretax Margin % : 18.38% (As of Jun. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Vytrus Biotech Pretax Margin %?

Pre-Tax margin is calculated as Pre-Tax Income divided by its Revenue. Vytrus Biotech's Pre-Tax Income for the six months ended in Jun. 2024 was €0.46 Mil. Vytrus Biotech's Revenue for the six months ended in Jun. 2024 was €2.50 Mil. Therefore, Vytrus Biotech's pretax margin for the quarter that ended in Jun. 2024 was 18.38%.

The historical rank and industry rank for Vytrus Biotech's Pretax Margin % or its related term are showing as below:

XMAD:VYT' s Pretax Margin % Range Over the Past 10 Years
Min: -26.51   Med: 6.82   Max: 12.97
Current: 12.97


XMAD:VYT's Pretax Margin % is ranked better than
84.08% of 999 companies
in the Biotechnology industry
Industry Median: -129.77 vs XMAD:VYT: 12.97

Vytrus Biotech Pretax Margin % Historical Data

The historical data trend for Vytrus Biotech's Pretax Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vytrus Biotech Pretax Margin % Chart

Vytrus Biotech Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Pretax Margin %
Get a 7-Day Free Trial -26.51 5.40 11.02 12.30 8.24

Vytrus Biotech Semi-Annual Data
Dec18 Dec19 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Pretax Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only 14.70 9.26 10.91 5.38 18.38

Competitive Comparison of Vytrus Biotech's Pretax Margin %

For the Biotechnology subindustry, Vytrus Biotech's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Vytrus Biotech's Pretax Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Vytrus Biotech's Pretax Margin % distribution charts can be found below:

* The bar in red indicates where Vytrus Biotech's Pretax Margin % falls into.


;
;

Vytrus Biotech Pretax Margin % Calculation

Pretax margin - also known as pretax profit margin is the ratio of Pretax Income divided by net sales or Revenue, usually presented in percent.

Vytrus Biotech's Pretax Margin for the fiscal year that ended in Dec. 2023 is calculated as

Pretax Margin=Pre-Tax Income (A: Dec. 2023 )/Revenue (A: Dec. 2023 )
=0.308/3.737
=8.24 %

Vytrus Biotech's Pretax Margin for the quarter that ended in Jun. 2024 is calculated as

Pretax Margin=Pre-Tax Income (Q: Jun. 2024 )/Revenue (Q: Jun. 2024 )
=0.46/2.503
=18.38 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Vytrus Biotech  (XMAD:VYT) Pretax Margin % Explanation

The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.

The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.

It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.

The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.


Vytrus Biotech Pretax Margin % Related Terms

Thank you for viewing the detailed overview of Vytrus Biotech's Pretax Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Vytrus Biotech Business Description

Traded in Other Exchanges
N/A
Address
Sant Gaieta 121, 2nd, Terrassa, Barcelona, ESP, 08221
Vytrus Biotech SA develops natural active ingredients on an industrial scale. The natural actives offered by the company include Nectaria Lithops, Olea Vitae, Turmeric zen, Capilia Longa, Qura Noni.

Vytrus Biotech Headlines

No Headlines